Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.8, 2004-01, pp. : 479-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite

On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance

Current Drug Metabolism, Vol. 10, Iss. 9, 2009-11 ,pp. : 981-997

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients

Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. : 235-247

Bentham Science Publishers

Access to resources Recommend Favorite

Is There Still a Room for Azathioprine Monotherapy in Inflammatory Bowel Disease?

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1471-1479

Bentham Science Publishers

Access to resources Recommend Favorite

Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy

By Connell W. Miller A.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 311-323

Adis International

Access to resources Recommend Favorite